newsfilter
← Latest News
PR Newswire·

I-MAB Filed 2023 Annual Report on Form 20-F

I-Mab (the "Company") (NASDAQ: IMAB), a U.S.-based, global biotech company, exclusively focused on the development and potential commercialization of ...